Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |